Appello Pharmaceuticals Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $10.5M
Latest Deal Amount
  • Investors
  • 2

Appello Pharmaceuticals General Information

Description

Developer of allosteric modulators of mGlu4 for the treatment of Parkinson's disease. The company's modulators are based on positive allosteric, enabling researchers in finding treatment of Parkinson's disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 3835 Cleghorn Avenue
  • Suite200
  • Nashville, TN 37215
  • United States
+1 (615) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Appello Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 28-Jun-2018 $10.5M 000.00 0000 Completed Pre-Clinical Trials
To view Appello Pharmaceuticals’s complete valuation and funding history, request access »

Appello Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00 00.000
To view Appello Pharmaceuticals’s complete cap table history, request access »

Appello Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of allosteric modulators of mGlu4 for the treatment of Parkinson's disease. The company's modulators are based
Drug Discovery
Nashville, TN
000.00
000 0000-00-00
00000000000 000.00

00000000

smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
000000000000000
South San Francisco, CA
00 As of 0000
00000
0000000000.

0000000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
0000 000000000
Calabasas, CA
00 As of 0000
0000
000000&0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Appello Pharmaceuticals Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Achaogen Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
0000000 Formerly VC-backed Calabasas, CA 00 0000 000000&0 0000
0000 Venture Capital-Backed San Diego, CA 0 00000 0000000000 0 00000
000000 000000000 Formerly PE-Backed Germantown, MD 0 000.00 000000000 000.00
To view Appello Pharmaceuticals’s complete competitors history, request access »

Appello Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Brian Laden Ph.D President, Chief Operating Officer & Board Member
To view Appello Pharmaceuticals’s complete executive team members history, request access »

Appello Pharmaceuticals Board Members (7)

Name Representing Role Since
Brian Laden Ph.D Self President, Chief Operating Officer & Board Member 000 0000
Howie Furst MD Deerfield Management Board Member 000 0000
Jeff Conn Ph.D Self Board Member 000 0000
Joseph Cook Jr. Mountain Group Partners Chairman 000 0000
Lee Limbird Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Appello Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Deerfield Management Venture Capital Minority 000 0000 000000 0
Mountain Group Partners Venture Capital Minority 000 0000 000000 0
To view Appello Pharmaceuticals’s complete investors history, request access »